IVRN — Innoveren Scientific Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.58m
- $0.45m
Brief: Medovex Corp Announces Name Change To H-Cyte And New Ticker Symbol
Brief: Nasdaq Announces Delisting Of Certain Securities
Brief: Medovex files for non-timely 10-Q
Brief: Medovex Corp announced that it has launched its DenerveX System device in Spain with distributor Prim SA
Brief: Medovex receives approval from Australia's TGA for its Denervex system
chairman of board
Brief: Medovex Corporation names Charlie Farrahar as CFO
Brief: Medovex Corporation Denervex System first cases to commence in Germany
Brief: John Stetson reports a 5.3 percent passive stake in Medovex
Brief: Medovex announces pricing of $2.69 mln concurrent registered direct offering
Brief: Medovex Corp updates European Union launch progress
Brief: Medovex receives first three commercial orders for DenerveX system
Brief: Medovex says three centers in EU will perform first in human cases for denervex system
Brief: Medovex files for mixed shelf offering of up to $20 mln - SEC filing
Brief: Medovex files for resale of up to 7.8 mln shares of co's stock
Brief: Medovex Corp says entered into a unit purchase agreement with selected accredited investors
Brief: Medovex enters into international distribution agreement with AlfaMed s.r.l.
Brief: Sorrento Therapeutics reports 5.9 pct passive stake in Medovex
Brief: Medovex Corporation enters into agreement with M.fast Technologies LTD